Victoria Socha
Articles by Victoria Socha
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Researchers at SCM25 presented interim results of the SPARTAN trial of sparsentan as a treatment for patients with IgAN.
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
Researchers presented results of an interim analysis of a study of finerenone among patients with CKD and type 2 diabetes.
Researchers assessed the burden of cardiovascular-kidney-metabolic (CKM) syndrome using NHANES 2001-2020 data.
Research examined outcomes associated with blood volume monitoring for patients on hemodialysis and hospitalized with HF.
Research explored kidney outcomes among young patients receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
A study compared the impact of conservative management of CKD vs transition to dialysis on risk for cognitive dysfunction.
NOBLE examined the efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent C3G or IC-MPGN.
A study examined the effects of adding dapagliflozin to treatment with tolvaptan in patients with ADPKD.
Previous studies suggest a link between CKD and sleep disorders, but the nature of the association is unclear.
A study examined the safety and noninferiority of kidney transplantation from donors with HIV to recipients with HIV.
A systematic review and meta-analysis evaluated the safety of statin use among kidney allograft recipients.
Does the prevalence of cardiovascular-kidney-metabolic syndrome stages vary by social determinants of health?
Is time to death from withdrawal of life-sustaining treatment is associated with kidney transplant outcomes?
The TRANSNEMIA study addressed the need for guidelines specific to anemia in kidney transplant recipients.
Researchers studied variation in AKI incidence with IV antihypertensive treatment after severe hypertension.
A study examined the efficacy and safety of conversion from treatment with the long-acting ESA MPG-EPO to vadadustat.
A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.